Exposure & Epidemiology
How Asbestos Exposure Was Measured Across Europe
How asbestos exposure was measured across Europe, including older exposure patterns, evidence limits, and practical context
Exposure & Epidemiology
How asbestos exposure was measured across Europe, including older exposure patterns, evidence limits, and practical context
Diagnosis, Pathology & Imaging
Rare presentations of epithelioid mesothelioma that mimic other tumours, and the immunohistochemical markers pathologists use to resolve them.
Resources & Support
Discover everything you need to know about mesothelioma and asbestos-related diseases, from their causes to treatments and prevention strategies.
Diagnosis, Pathology & Imaging
Unlocking the histological challenges of mesothelioma: how to distinguish between benign and malignant mesothelial processes.
Treatment & Supportive Care
A detailed look at mesothelioma and the wider family of asbestos-related illnesses, covering how they develop, how they present, and how they are found.
Research & Emerging Therapies
How asbestos fibres affect mesothelial cells, with cautious context about older research and what it may mean today
Legal & Compensation
How australian courts framed asbestos disease claims, with general litigation context and clear limits on case-specific advice
Diagnosis, Pathology & Imaging
The full diagnostic pathway for suspected mesothelioma, from first imaging and fluid sampling through biopsy, staging, and confirming the diagnosis.
Exposure & Epidemiology
How early south african research linked asbestos and mesothelioma, including older exposure patterns, evidence limits, and practical context
Page 6 of 13